Molecular Imaging

About this Journal

Aims and scope

Molecular Imaging is a peer-reviewed journal highlighting the breadth of molecular imaging research from basic science to preclinical studies to human applications. Molecular Imaging covers all imaging modalities including:

  • Nuclear
  • Optical
  • Magnetic Resonance
  • Ultrasound
  • Photoacoustic
  • CT
  • Magnetic Particle Imaging

Additionally, Molecular Imaging covers:

  • Development, application and validation of molecular imaging contrast agents
  • Probes for cellular and molecular targets (proteins, receptors, enzymes, genes and gene products that are present as a result of normal function or disease)
  • In vitro and in vivo assay methodology
  • Quantitative imaging and kinetic modeling
  • Animal model systems supporting targeted imaging approaches
  • Development, testing and validation of imaging devices

Molecular Imaging has been continuously published since 2002. The journal encourages the submission of unsolicited Reviews and papers reporting null or negative results in addition to Research Articles.

This journal will be of particular interest to:

  • Molecular Imaging Scientists and Physicians
  • Basic and Translational Cancer Researchers
  • Medical Physicists
  • Radiopharmaceutical and Medicinal Chemists
  • Cell and Molecular, Chemical, and Systems Biologists
  • Pharmacologists

    The SAGE Hindawi Partnership

    This journal is published by Hindawi as part of a publishing collaboration with SAGE Publishing. It is a fully Open Access journal produced under the Hindawi and SAGE Publishing brands.
     

      Bibliographic information

      ISSN: 1536-0121 (print)
      ISSN: 1536-0121 (online)
      DOI: 10.1155

        Contact

        Editorial enquiries should be directed to help@hindawi.com

          Molecular Imaging
          Publishing Collaboration
          More info
          Sage logo
           Journal metrics
          Acceptance rate-
          Submission to final decision-
          Acceptance to publication-
          CiteScore3.600
          Impact Factor2.763
           Submit

          We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.